Partial splenectomy before a hematopoietic stem cell transplantation in children

被引:9
|
作者
Hall, JG
Kurtzberg, J
Szabolcs, P
Skinner, MA
Rice, HE
机构
[1] Duke Univ, Med Ctr, Dept Surg, Div Pediat Surg, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Pediat Bone Marrow & Stem Cell Transplant Program, Durham, NC 27710 USA
关键词
partial splenectomy; hematopoietic stem cell transplantation; engraftment; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; MYELOFIBROSIS; SEVERITY; LEUKEMIA; SPLEEN;
D O I
10.1016/j.jpedsurg.2004.09.047
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Hematopoietic stem cell (HSC) engraftment is delayed in children with hypersplenism, and splenectomy may improve HSC engraftment. However, the use of total splenectomy in children is limited because of concerns for postsplenectomy sepsis. In this study, the authors sought to assess the role of partial splenectomy for children with hypersplenism undergoing HSC transplantation. Methods: Five children with a variety of conditions and associated hypersplenism underwent partial splenectomy before an HSC transplantation at the authors' institution between 2000 and 2003. Primary outcome measures were rates of neutrophil and platelet engraftment. Secondary outcome measures included perioperative complications, splenic regrowth, graft-versus-host disease, and infection rate. All outcomes were compared with recipients of an HSC transplant from both age-matched nonsplenectomized children (n = 497) and hypersplenic children who underwent total splenectomy (n = 10). Outcomes were compared using Wilcoxon's rank sum test. Results: The rate of both neutrophil and platelet engraftment was faster in children who underwent either partial or total splenectomy as compared with nonsplenectomized children (mean rates of neutrophil engraftment were 26, 19, and 19 days for the nonsplenectomy, total splenectomy, and partial splenectomy groups, respectively; mean rates of platelet engraftment were 97, 37, and 45 days for the nonsplenectomy, total splenectomy, and partial splenectomy groups, respectively). Graft-versus-host disease rates were similar between the 3 groups. The mean percentage of splenic regrowth after partial splenectomy was 39%. There were no perioperative complications. Conclusions: Partial splenectomy may be safely performed before HSC transplantation and, similar to total splenectomy, may improve the rate of HSC engraftment. Although this series has a limited number of patients, the use of partial splenectomy appears to be safe and may allow for splenic salvage to minimize the risk of postsplenectomy sepsis. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 50 条
  • [1] The Impact of Splenectomy in Myelofibrosis Patients before Allogeneic Hematopoietic Stem Cell Transplantation
    Robin, Marie
    Zine, Maryem
    Chevret, Sylvie
    Meignin, Veronique
    Munoz-Bongrand, Nicolas
    Moatti, Hannah
    Xhaard, Alienor
    de Fontbrune, Flore Sicre
    de latour, Regis Peffault
    Sarfati, Emile
    Socie, Gerard
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (06) : 958 - 964
  • [2] Splenectomy and partial splenectomy improve hematopoietic stem cell engraftment in hypersplenic mice
    Tracy, Elisabeth T.
    Talbot, Lindsay J.
    Kurtzberg, Joanne
    Rice, Henry E.
    JOURNAL OF PEDIATRIC SURGERY, 2010, 45 (06) : 1365 - 1369
  • [3] Hematopoietic Stem Cell Transplantation in Children
    Kolins, Julie A.
    Zbylut, Cara
    McCollom, Susan
    Aquino, Victor M.
    CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2011, 23 (02) : 349 - +
  • [4] Gastrointestinal peptides in children before and after hematopoietic stem cell transplantation
    Szymon Skoczeń
    Magdalena Rej
    Kinga Kwiecińska
    Danuta Pietrys
    Przemysław J. Tomasik
    Małgorzata Wójcik
    Wojciech Strojny
    Agnieszka Dłużniewska
    Katarzyna Klimasz
    Kamil Fijorek
    Michał Korostyński
    Marcin Piechota
    Walentyna Balwierz
    BMC Cancer, 20
  • [5] Gastrointestinal peptides in children before and after hematopoietic stem cell transplantation
    Skoczen, Szymon
    Rej, Magdalena
    Kwiecinska, Kinga
    Pietrys, Danuta
    Tomasik, Przemyslaw J.
    Wojcik, Malgorzata
    Strojny, Wojciech
    Dluzniewska, Agnieszka
    Klimasz, Katarzyna
    Fijorek, Kamil
    Korostynski, Michal
    Piechota, Marcin
    Balwierz, Walentyna
    BMC CANCER, 2020, 20 (01)
  • [6] Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children
    Franca, Raffaella
    Stocco, Gabriele
    Favretto, Diego
    Giurici, Nagua
    Decorti, Giuliana
    Rabusin, Marco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (08) : 18601 - 18627
  • [7] Pulmonary complications following hematopoietic stem cell transplantation in children
    Ciki, Kismet
    Dogru, Deniz
    Kuskonmaz, Baris
    Emiralioglu, Nagehan
    Yalcin, Ebru
    Ozcelik, Ugur
    Uckan-Cetinkaya, Duygu
    Kiper, Nural
    TURKISH JOURNAL OF PEDIATRICS, 2019, 61 (01) : 59 - 70
  • [8] Rituximab for indolent lymphomas before and after allogeneic hematopoietic stem cell transplantation
    Cieri, Nicoletta
    Di Bartolo, Orazio
    Corradini, Paolo
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 469 - 475
  • [9] Salivary Changes before and after Hematopoietic Stem Cell Transplantation: A Systematic Review
    van Leeuwen, Stephanie J. M.
    Potting, Carin M. J.
    Huysmans, Marie-Charlotte D. N. J. M.
    Blijlevens, Nicole M. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (06) : 1055 - 1061
  • [10] Acute pericarditis before engraftment in hematopoietic stem cell transplantation
    Shinohara, A.
    Honda, A.
    Nukina, A.
    Takaoka, K.
    Tsukamoto, A.
    Hangai, S.
    Kogure, Y.
    Kobayashi, T.
    Yamazaki, S.
    Ueda, K.
    Nakamura, F.
    Nannya, Y.
    Kurokawa, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 (03) : 459 - 461